Glaxosmithkline Consumer Healthcare - Q1FY13 Result Flash - Ventura

Key Takeaways

- Glaxosmithkline Consumer Healthcare Ltd reported revenues of Rs.758.4 crore in Q1FY13 v/s Rs.673.9 crore in Q1 FY12.

- EBITDA is Rs.139.4 crore in Q1 FY13 v/s Rs.119 crore in Q1 FY12.

- EBIDTA margins were 18.4% in Q1 FY13 v/s 17.7% in Q1 FY12.

- The company posted a net profit of Rs.106.6 crore in this quarter v/s Rs.82.5 crore YoY.

- PAT margins increased by 190 bps from 12.2% in Q1 FY12 to 14.1% in Q1 FY13.

Outlook: Very good results posted by the company.

Source : Equity Bulls

Keywords